Elekta striving to build radiation therapy infrastructures and save lives of cancer patients in Africa

In Africa, cancer kills more people than HIV/AIDS, malaria and tuberculosis combined. Approximately 40 percent of cancer cases can be prevented and 40 percent can be cured with the right treatment. Together with Elekta, ministries of health in almost a dozen African nations are working to build up their radiation therapy infrastructures and save lives.

More than 50 percent of all cancer patients worldwide would benefit from radiation therapy during the course of their disease, either as the sole therapy or in combination with surgery and chemotherapy. Despite being home to 85 percent of the world's population, less than 35 percent of the world's radiotherapy facilities are in low-income countries. Africa is a prime example of the shortfall that leaves most cancer patients in low-income countries without access to potentially life-saving radiation therapy treatment.

Ian Alexander, Executive Vice President of Elekta's Region Europe, Africa, Latin America and Middle East, says: "Most sub-Saharan countries lack the facilities and trained personnel necessary to provide effective prevention, early detection or adequate treatment of cancer. Elekta is striving to introduce to these countries value-based health systems that deliver high-quality care at low total costs."

Access to radiation therapy on the continent has been hampered by a variety of factors, including education and training. Elekta is committed to improving these circumstances and is investing substantially in its Learning and Innovation Center (LINC) training facility in Cape Town (South Africa). Here, clinicians can learn more about the use of linear accelerators, oncology information systems and treatment planning systems. The company is also actively working to address the unmet need for radiation therapy solutions.

"It is totally unacceptable that fewer than half of Africa's cancer patients have access to any treatment services," Alexander says. "Elekta is determined to change the outlook for millions of patients in Sub-Saharan Africa, by providing affordable solutions."

SOURCE Elekta

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Elekta. (2023, September 12). Elekta striving to build radiation therapy infrastructures and save lives of cancer patients in Africa. News-Medical. Retrieved on December 22, 2024 from https://www.news-medical.net/news/20150506/Elekta-striving-to-build-radiation-therapy-infrastructures-and-save-lives-of-cancer-patients-in-Africa.aspx.

  • MLA

    Elekta. "Elekta striving to build radiation therapy infrastructures and save lives of cancer patients in Africa". News-Medical. 22 December 2024. <https://www.news-medical.net/news/20150506/Elekta-striving-to-build-radiation-therapy-infrastructures-and-save-lives-of-cancer-patients-in-Africa.aspx>.

  • Chicago

    Elekta. "Elekta striving to build radiation therapy infrastructures and save lives of cancer patients in Africa". News-Medical. https://www.news-medical.net/news/20150506/Elekta-striving-to-build-radiation-therapy-infrastructures-and-save-lives-of-cancer-patients-in-Africa.aspx. (accessed December 22, 2024).

  • Harvard

    Elekta. 2023. Elekta striving to build radiation therapy infrastructures and save lives of cancer patients in Africa. News-Medical, viewed 22 December 2024, https://www.news-medical.net/news/20150506/Elekta-striving-to-build-radiation-therapy-infrastructures-and-save-lives-of-cancer-patients-in-Africa.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Elekta introduces new Leksell Gamma Knife Icon to treat patients with brain disease